Disclosure: Bullpen receives compensation from Timbercreek Financial for research coverage. Timbercreek is also an IR client of LodeRock Advisors, an affiliate of Bullpen.
Timbercreek Financial (TF) reported a challenging Q3, which missed expectations on the back of $40M of ECLs - driven mainly by its Vancouver exposure…

… which has moved into Stage 3 and should result in temporary pressure on distributable income, with management guiding to a 135% payout ratio in Q4.

At $134M of net staged exposure (73% of total), resolving Vancouver is the key driver for a “return to normal” staged balance of 6-8%…

… and management is focused on accelerating a sale of the main asset (Granville block) towards a Q1/27 close, with recovered capital going back out the door in what’s a healthy origination backdrop.

With no firm deal in place yet, our base case now assumes a temporary distribution cut in Q2 - which should be restored as redeployed capital begins to produce…

… given MICs like TF pay out all income to shareholders by design, as it results in zero tax burden. We’re not sure investors understand this dynamic, with shares moving 14% lower (a similar move to Fiera & Allied who cut for different reasons)…

… resulting in a market-implied impairment of $219M or 37% dividend cut to $0.43 per share. That’s against $190M of net staged loans and $0.51 of DI per share on the current performing book…

… and materially worse than our revised base case, which results in a book value per share >50% above current prices even with $27M more impairment - as we explore in the full report below:




